{{Rsnum
|rsid=1722784
|Gene=ANXA9
|Chromosome=1
|position=150989393
|Orientation=minus
|GMAF=0.2865
|Gene_s=ANXA9
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 12.4 | 56.6 | 31.0
| HCB | 2.2 | 27.2 | 70.6
| JPT | 2.7 | 32.7 | 64.6
| YRI | 0.7 | 15.6 | 83.7
| ASW | 1.8 | 33.3 | 64.9
| CHB | 2.2 | 27.2 | 70.6
| CHD | 2.8 | 25.7 | 71.6
| GIH | 5.9 | 31.7 | 62.4
| LWK | 0.9 | 11.0 | 88.1
| MEX | 10.5 | 49.1 | 40.4
| MKK | 0.0 | 24.5 | 75.5
| TSI | 13.7 | 45.1 | 41.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21926416
|Trait=None
|Title=Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.
|RiskAllele=
|Pval=0.000002
|OR=1.1200
|ORtxt=[NR]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}